中国药房2011，Vol.22Issue(10)：877-881,5.
保肝药在预防与治疗抗结核药所致肝损伤中的利用分析
Analysis of the Utilization of Hepatoprotective Agents in Prevention and Treatment of Anti-tuberculosis Drugs Induced Liver Damage
赵良义 1邵艳新 1董书梅 1郭雁 1李国兴1
作者信息
- 1. 河北省胸科医院药学部,石家庄市,050041
- 折叠
摘要
Abstract
OBJECTIVE: To study the current situation and tendency of the utilization of hepatoprotective agents in the prevention and treatment of anti-tuberculosis induced liver damage. METHODS: The utilization of hepatoprotective agents in the prevention and treatment of anti-tuberculosis induced liver damage in our hospital from 2005 to 2009 were analyzed statistically in respect of variety, amount, consumption sun, DDDs and DDC. RESULTS: Hepatoprotective agents used in our hospital involved 24 varieties. The consumption sum and DDDs of drugs increased by 280％ and 195％ during five years. The consumption sum of Reduced glutathione for injection and Tiopronin Injection were in the top 3 place during five years. Glucurolactone tablets took up the first place in the list of DDDs during five years. DDDs of Reduced glutathione for injection and Chinese patent medicine increased by 265％ and 259％ respectively during five years. CONCLUSION: Hepatoprotective agents show a rising trend in the prevention and treatment of anti-tuberculosis drugs induced liver damage.关键词
保肝药/抗结核药/肝损伤/利用分析分类
医药卫生引用本文复制引用
赵良义,邵艳新,董书梅,郭雁,李国兴..保肝药在预防与治疗抗结核药所致肝损伤中的利用分析[J].中国药房,2011,22(10):877-881,5.
